45

DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID

Embed Size (px)

Citation preview

Page 1: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
Page 2: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

DEFINITION

EPIDEMIOLOGY

MECHANISM

PATHOPHYSIOLOGY

INITIATING FACTORS

SIGN AND SYMPTOMS

DIAGNOSIS

TREATMENT

CASE REPORT

Page 3: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

It is a state of absolute or relative insulin

deficiency aggravated by ensuing

hyperglycemia,dehydration & acidosis

producing derangements in

intermediatory metabolism.

DKA is far more characteristic feature of

type 1 Diabetes mellitus than of type 2

Diabetes mellitus.

Page 4: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Blood glucose level > 250 mg/dl

Blood pH < 7.3

Ketones in serum > 5 m.eq/L

Page 5: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

DKA is reported in 2-5% of known type 1 diabetic patients in industrialized countries, while it occurs in 35-40% of such patients in Africa.

DKA at the time of first diagnosis of diabetes mellitus is reported in only 2-3% in western Europe, but is seen in 95% of diabetic children in Sudan. Similar results were reported from other African countries

Page 6: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

A; The basic underlying mechanisms are: Absolute deficiency of circulating insulin. secretion of insulin counterregulatory

hormones; glucagon, adrenaline, cortisol and growth hormone.

Page 7: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
Page 8: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
Page 9: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

B-This leads to disturbances in the following physiological processes:

-glucose utilization (hyperglycemia). - proteolysis ( amino acids, glutamine and

alanine). - lipolysis ( glycerol and FFAs). - glycogenolysis (breakdown of muscle

glycogen lactate). - gluconeogensis (glutamine & alanine &

glycerol & lactate are the precursors).

Page 10: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

1:HYPERGLYCEMIA:Serum osmolality → insulin resistance

increases → hyperglycemia worsens. 2:ACIDOSIS:

Decrease insulin → increase lipolysis →ketone bodies → ketonemia → ketone anions→ depletes alkali reserves →kussmaul respiration.

3:DEHYDRATION:

Page 11: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Hyperglycemia → hyperosmolality →increase urination

Nausea and vomiting → further water loss

Decrease renal blood flow → GFR decrease Hypovolumic shock 4:ELECTROLYTE IMBALANCE Loss of potassium Blood urea nitrogen

Page 12: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
Page 13: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

InfectionPneumonia & UTI most commonly Inadequate use of insulin

Not taking insulin.

Page 14: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Emotional stress Drugs:

CorticosteroidsAntihistaminesThiazide Diuretics Pancreatitis

Page 15: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

A-Symptoms of DKA: 1-Classic symptoms of hyperglycemia: short

period of time: Polyuria, polydipsia, weight loss and thirst. 2-Other symptoms: - General weakness, malaise and lethargy. -Nausea, vomiting and abdominal pain. - Perspiration. - Disturbed consciousness and confusion. 3-Symptoms of underlying infections or other

conditions; fever, abdominal pain, dysuria, chest pain…etc

Page 16: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

a-General signs: Ill appearance and disturbed consciousness.

b-Signs of dehydration: -Skin: Dry, hot, flushed, and loss of skin turgor. -Tongue: Dry (sometimes woody tongue). -Eyes: Sunken eyes and dark circles under the eyes. c-Vital signs: -Tachycardia, hypotension and tachypnea. d-Specific signs: -Ketotic breath: A strong, fruity breath odour (similar

to nail polish remover or acetone). -Acidotic breath (Kussmaul's respiration): deep and

rapid. -Abdominal tenderness.

Page 17: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
Page 18: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

You should suspect DKA if a diabetic patient presents with:

Dehydration. Acidotic (Kussmaul’s) breathing, with a fruity

smell (acetone). Abdominal pain &\or distension. Vomiting. An altered mental status ranging from

disorientation to coma.

Page 19: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

High WCC: may be seen in the absence of infections.

BUN: may be elevated with prerenal azotemia secondary to dehydration.

Creatinine: some assays may cross-react with ketone bodies, so it may not reflect true renal function.

Serum Amylase: is often raised, & when there is abdominal pain, a diagnosis of pancreatitis may mistakenly be made

Page 20: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

The main lines of management include:

A-Primary assessment: -Volume status and degree of dehydration. -Blood pressure and cardiac condition. -Degree of consciousness. -Degree of acidosis. -Precipitating disease

Page 21: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

-Blood glucose (using glucometers) every hour.

-Electrolytes and pH every 4 hours. -Urine for glucose and ketones every 4

hours

Page 22: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

1-General measures: -Airway and O2 inhalation if needed. -IV line. -Urinary Foley's catheter (if in shock). -NGT (Nasogastric Tube): to avoid gastric

dilatation and protection from aspiration . -Thrombosis prophylaxis: 5000 units of heparin

SC/12 hours. -Empiric use of 3rd generation cephalosporin

antibiotics.

Page 23: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

2-Specific measures: Successful therapy of hyperglycemic crises requires

the administration of: a-Fluids: 1- Correct volume deficit and hypotension. 2- Improve tissue perfusion. 3-Improve insulin sensitivity ( insulin

counterregulatory hormones). 4-Improve glomerular filtration rate: i-↑ excretion of large amount of glucose in urine. ii-Clears hyperketonemia. 5- Correct metabolic acidosis.

Page 24: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

b-Insulin: Reversal of metabolic abnormalities :

i-Corrects hyperglycemia. ii-Inhibits ketogenesis.

c-Potassium: Prevents complications associated with hypokalemia.

Page 25: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

The expected volume deficits calculated as: 5-10% of body wt in DKA (3-6 liters). 15 % of body wt in NKHH (9 liters). Replacement therapy should be given within 24 hours

after admission: 50% of the deficit in the first 4 hours. 50% of the deficit in the next time for up to 24

hours, guided by ongoing clinical evaluation. For children and adolescents (less than 20 years): Fluids are given as 10-20 ml/kg/hour in the first four

hours. Then given guided by clinical evaluation

Page 26: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

1-Normal saline (0.9% sodium chloride). Advantages: -Available all the time. -Rapid expansion of extracellular compartment. -Slow decline of extracellular osmolarity. -Slow rate of cerebral edema evolution. Disadvantages: May accentuate hypernatrimia if

present. Indications: -All cases of DKA. -Initial (1st 2 liters) in NKHH state.

Page 27: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Standard low dose insulin regimen: This regimen is the only effective therapy in DKA & NKHH state:

1-Inhibits ketogenesis and gluconeogenesis. 2- Presence of insulin resistance state

secondary to: a- Stress insulin counterregulatory hormones. b- Ketone bodies & FFAs. c- Hemoconcentration and electrolytes

imbalance. d- Hyperosmolarity. e- Infection.

Page 28: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Type of insulin : Regular : Rapid or short acting insulin U-40 & U-100.

Regimen: Initial bolus: 0.1 U/kg body wt given IV. Maintenance: 0.1 U/kg/body wt /hour: a- IV Infusion set: Add 100 units of regular

insulin +500 ml saline i.e. every 5 cc fluid contains 1 unit of insulin

b-IV infusion set is not available:IM route.

Page 29: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Initially: Mild to moderate hypokalemia occur in patients with DKA.

Later on: After initiation of Insulin therapy Correction of acidosis lead to hypokalemia.

Volume expansion & hydration

Page 30: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Monitoring: Blood glucose by glucometer every hour. Urine analysis for glucose and ketones every 4 hours. Order IV glucose 5% (second line) once blood glucose

reaches: < 250 mg/ dl in DKA. < 300 mg/ dl in NKHH state. Re-evaluate parameters of rehydration

establishment: Stable blood pressure. Normal urine output. Clinical signs of rehydration.

Page 31: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Evaluate the criteria for stopping hourly insulin regimen (resolving DKA): Acidosis corrected clinically and by pH. Negative ketoneuria. Eating. Patient looks good and feels good.

Page 32: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

1-Complications of associated illnesses e.g. sepsis or MI.

2-Adult respiratory distress syndrome. 3-Thromboembolism (elderly). 4-Complications of treatment: a-Hypokalemia: Which may lead to: -Cardiac arrhythmias. -Cardiac arrest. -Respiratory muscle weakness.

Page 33: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

b-Hypoglycemia.

c-Overhydration and acute pulmonary edema: particularly in:

-Treating children with DKA.

-Adults with compromised renal or cardiac function.

-Elderly with incipient CHF.

Page 34: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
Page 35: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

A female patient lal mai was admitted to the medical ward 4 of BVH and was suffering from pain in right hypochondrium and diabetic ketoacidosis.

Age:80yrs Weight:60kg Family history:Insignificant Socioeconomic:Poor

Page 36: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

Vital Signs: B.P:130/90mmhg Temperature:101F Pulse:110 per min

Page 37: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

DRUG DOSE ROUTE FORM FREQUENCY

Omeprazole 40mg/100m IV INJ. NOT

Qzone 1.0gm IV INJ. MENTIONED

Maxolon 10mg/2ml IV INJ.

Avil 25mg/2ml IV INJ.

lasix 20mg/2ml IV INJ.

Page 38: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

PARTIAL DIFFERENTIAL

Pain in right hypochondrium Diabetic ketoacidosis

Page 39: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

UNTREATED INDICATION

IMPROPER DRUG SELECTION

SBTHERAPEUTIC DOSE

FAILURE TO RECEIVE DRUGS

Ketoacidosis is untreated indication

improper drug selection

No drug Nursing staff was available all the time

OVER DOSE ADVERSE DRUG EVENTS

DRUG INTERACTIONS

DRUG USE WITHOUT INDICATION

No drug Headache rash dizziness diarrhea insomnia dehydration

No clinically significant drug interaction

Lasix was prescribed without any indication.

Page 40: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

FINDINGS: The patient has objective evidence of pain in

the right hypochondrium. Additionaly laboratory diagnosis revealed

ketoacidosis

Page 41: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

ASSESMENT OF PROBLEM: Therapy is given for treatment of pain in right

hypochondrium. No therapy is given for the management of

diabetic ketoacidosis

Page 42: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

PROBLEM RESOLUTION: Patient should be given electrolyte

replacement therapy for the management of diabetic ketoacidosis.

MONITORING: Blood sugar level and urine ketone bodies

level should be monitored in the patient.

Page 43: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

SAMPLECOLLECTION $ PROCESSING

TEST RANGE NORMAL VALUES

PHYSILOGIC BASIS

INTERPRETATION

COMMENTS

URINE KETONES

NORMAL; o.o5 –o.3mg/dlPATIENTVALUE; 0.5mg/dl

Ketones which results from the metabolism of fatty acids $ fat consist of 3 substances… ACETONE, β-HYDROXY BUTYRIC ACID $ ACETOACETIC ACID

Ketouria occur in following conditions;1METABOLICCONDITIONS2.DIETARY CONDITIONS 3.HIGH METABOLISM

Urine ketones gives an indication of diabetic ketoacidosis

Page 44: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID

The disease of the patient was not properly treated and she was given incomplete treatment of the disease.

Patient should be properly managed about the treatment.

Pharmacist intervention is strictly required.

Page 45: DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID